Published in Am J Manag Care on November 01, 2005
The role of uric acid in pediatric hypertension. J Ren Nutr (2007) 0.89
Anti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic Content. BMC Complement Altern Med (2017) 0.75
Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial. J Adv Res (2017) 0.75
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet (2009) 3.36
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum (2008) 2.31
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13
Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med (2002) 2.01
The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol (2009) 1.82
Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol (2008) 1.79
Validity of gout diagnoses in administrative data. Arthritis Rheum (2007) 1.62
A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum (2009) 1.59
Regional distribution of adult rheumatologists. Arthritis Rheum (2013) 1.58
Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis. Arthritis Rheumatol (2015) 1.58
Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol (2010) 1.53
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Res Ther (2011) 1.53
Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol (2002) 1.46
Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. Arthritis Rheum (2006) 1.43
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum (2011) 1.38
The impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2017) 1.38
Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol (2003) 1.35
Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum (2011) 1.27
Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol (2010) 1.24
Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol (2009) 1.19
Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis (2013) 1.18
Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice. Arthritis Care Res (Hoboken) (2011) 1.16
Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res (Hoboken) (2013) 1.10
Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol (2014) 1.10
Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum (2013) 1.10
Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum (2003) 1.07
Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans. Clin Orthop Relat Res (2009) 1.07
Environmental exposures and rheumatoid arthritis risk. Curr Rheumatol Rep (2011) 1.06
IL-6 and its receptors in coronary artery disease and acute myocardial infarction. Cytokine (2013) 1.05
Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis (2012) 1.04
Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis (2010) 1.04
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy. Arthritis Res Ther (2010) 1.04
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial. Arthritis Rheum (2013) 1.01
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects. Arthritis Res Ther (2011) 0.99
The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol (2008) 0.99
Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. J Rheumatol (2012) 0.98
Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease. Arthritis Rheum (2013) 0.96
Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum (2013) 0.96
Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial. J Rheumatol (2013) 0.96
Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol (2005) 0.95
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin (2009) 0.95
Impact of total shoulder arthroplasty on generic and shoulder-specific health-related quality-of-life measures: a systematic literature review and meta-analysis. J Bone Joint Surg Am (2012) 0.93
Health-related quality of life among self-reported arthritis sufferers: effects of race/ethnicity and residence. Qual Life Res (2006) 0.91
Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.91
Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis (2012) 0.90
Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. J Rheumatol (2013) 0.90
Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices. J Rheumatol (2003) 0.89
Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis (2010) 0.89
Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol (2012) 0.88
Minocycline-induced hyperpigmentation in rheumatoid arthritis. J Clin Rheumatol (2008) 0.88
Organic dust, lipopolysaccharide, and peptidoglycan inhalant exposures result in bone loss/disease. Am J Respir Cell Mol Biol (2013) 0.87
Switching anti-TNF-alpha agents: what is the evidence? Curr Rheumatol Rep (2007) 0.86
Recent advances in the epidemiology of gout. Curr Rheumatol Rep (2005) 0.86
Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics. Arthritis Rheum (2004) 0.86
The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum (2003) 0.85
Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression. Arthritis Rheum (2009) 0.84
Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 0.84
Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthritis Res Ther (2012) 0.83
Relationship between air pollution and positivity of RA-related autoantibodies in individuals without established RA: a report on SERA. Ann Rheum Dis (2013) 0.83
Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. J Periodontol (2014) 0.82
To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis. Arthritis Rheum (2011) 0.82
Rheumatoid arthritis patients are not at increased risk for 30-day cardiovascular events, infections, or mortality after total joint arthroplasty. Arthritis Res Ther (2013) 0.82
Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. Arthritis Rheum (2010) 0.81
Musculoskeletal ultrasound objective structured clinical examination: an assessment of the test. Arthritis Care Res (Hoboken) (2014) 0.80
Dual-energy X-ray absorptiometry and evaluation of the osteoporosis self-assessment tool in men with rheumatoid arthritis. J Clin Densitom (2009) 0.80
Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis. Ann Rheum Dis (2013) 0.79
Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis. Rheumatology (Oxford) (2014) 0.79
Vitamin D supplementation protects against bone loss following inhalant organic dust and lipopolysaccharide exposures in mice. Immunol Res (2015) 0.79
A case of isolated sacral and pelvic sarcoidosis diagnosed by bone marrow biopsy. J Clin Rheumatol (2003) 0.78
Help stop tooth decay...and prevent RA? J Rheumatol (2010) 0.78
Performance of self-reported measures for periodontitis in rheumatoid arthritis and osteoarthritis. J Periodontol (2015) 0.77
Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant. Immunol Res (2014) 0.77
Hydroxychloroquine: a diabetic drug in disguise? BMJ Case Rep (2009) 0.77
Cardiovascular risk and the use of biologic agents in rheumatoid arthritis. Curr Rheumatol Rep (2014) 0.77
Body mass index and the rheumatoid arthritis swollen joint count: an observational study. Arthritis Care Res (Hoboken) (2013) 0.76
Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol (2017) 0.75
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis. J Rheumatol (2013) 0.75
Physician preference: filling the evidence gap. Arthritis Care Res (Hoboken) (2010) 0.75
CASPASE-12 and rheumatoid arthritis in African-Americans. Immunogenetics (2014) 0.75
Rheumatoid arthritis incidence: what goes down must go up? Arthritis Rheum (2010) 0.75
Gout as a manifestation of familial juvenile hyperuricemic nephropathy. J Clin Rheumatol (2014) 0.75
Use of Biologic Therapy in Racial Minorities With Rheumatoid Arthritis From 2 US Health Care Systems. J Clin Rheumatol (2017) 0.75
Disease characteristics and treatment patterns in veterans with rheumatoid arthritis and concomitant hepatitis C infection. Arthritis Care Res (Hoboken) (2015) 0.75
Spinal epidural abscess following minimally invasive dental examination in a rheumatoid arthritis patient receiving methotrexate, glucocorticoids, and anti-tumor necrosis factor therapy. J Clin Rheumatol (2015) 0.75
Allopurinol Medication Adherence as a Mediator of Optimal Outcomes in Gout Management. J Clin Rheumatol (2017) 0.75
Disseminated giant cell arteritis with inflammatory arthritis and C-ANCA. J Clin Rheumatol (2005) 0.75